Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries

Genenta Science S.p.A. - American Depositary Shares (NQ:GNTA)

2.798 +0.398 (+16.58%)
Streaming Delayed Price Updated: 10:12 AM EDT, Oct 29, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Genenta Science S.p.A. - American Depositary Shares

< Previous 1 2 3 Next >
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
 
Via Benzinga
Why Teradyne Shares Are Trading Higher By More Than 20%; Here Are 20 Stocks Moving Premarket
 
Via Benzinga
Wondering what's happening in today's after-hours session?
As the regular session of the US market on Tuesday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment. 
Via Chartmill
Which stocks are moving on Monday?
Looking for insights into the US markets one hour before the close of the markets on Monday? Delve into the top gainers and losers of today's session and gain valuable market intelligence. 
Via Chartmill
Which stocks have an unusual volume on Monday?
These stocks have an unusual volume in today's session 
Via Chartmill
Keep an eye on the top gainers and losers in Monday's session.
Let's have a look at what is happening on the US markets in the middle of the day on Monday. Below you can find the top gainers and losers in today's session. 
Via Chartmill
12 Health Care Stocks Moving In Monday's Intraday Session
 
Via Benzinga
Gold Falls 3%; Carter's Shares Gain After Q3 Earnings
 
Via Benzinga
Which stocks are gapping on Monday?
The session on Monday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session. 
Via Chartmill
Nasdaq Surges 300 Points; Keurig Dr Pepper Shares Jump After Q3 Results
 
Via Benzinga
These stocks are moving in today's pre-market session
Before the US market kicks off on Monday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers. 
Via Chartmill
12 Health Care Stocks Moving In Monday's Pre-Market Session
 
Via Benzinga
Why Avidity Biosciences Shares Are Trading Higher By Around 42%; Here Are 20 Stocks Moving Premarket
 
Via Benzinga
Genenta Announces Pricing of $15.0 Million Registered Direct Offering of American Depositary Shares
From GENENTA SCIENCE SPA
Via GlobeNewswire
12 Health Care Stocks Moving In Friday's After-Market Session
 
Via Benzinga
Get insights into the top gainers and losers of Friday's after-hours session.
The US market regular session of Friday is over, let's have a look at the top gainers and losers in the after hours session today. 
Via Chartmill
Myseum (NASDAQ: MYSE) CEO Darin Myman Highlights Privacy-Driven Future of Social Media – More Stocks Inside
Via AB Newswire
Topics Artificial Intelligence Intellectual Property
12 Health Care Stocks Moving In Friday's Intraday Session
 
Via Benzinga
Dow Jumps Over 500 Points; US Consumer Sentiment Declines In October
 
Via Benzinga
Topics Stocks
Nasdaq Surges 1%; Procter & Gamble Posts Upbeat Earnings
 
Via Benzinga
Genenta Extends Collaboration With Anemocyte To Boost Off-The-Shelf Genetic Therapy Production
Genenta Science shares jumped ~324% premarket to $13.69 after expanding its plasmid DNA collaboration with ANEMOCYTE. 
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
 
Via Benzinga
GNTA Stock Skyrockets 300% Pre-Market Toward Record Highs: What’s Driving The Super Rally?
Genenta Science shares surged 300% in premarket trading on Friday after announcing an expanded collaboration with ANEMOCYTE. 
Via Stocktwits
Genenta and Anemocyte Announce Strategic Partnership to Advance Off-The-Shelf LVV Plasmid DNA Production
From GENENTA SCIENCE SPA
Via GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
 
Via Benzinga
Genenta Announces Long-Term Follow-Up Observations in Brain Tumor (GBM) Study with Emerging Survival Signals
Genitourinary Tumor Study Ongoing with Active Screening and Enrollment 
From GENENTA SCIENCE SPA
Via GlobeNewswire
Genenta and Anemocyte announce a collaboration for the manufacturing of starting materials for cutting-edge cell-based therapies
Anemocyte established Cell Banks and Plasmids for Viral Vector Production 
From GENENTA SCIENCE SPA; Anemocyte
Via GlobeNewswire
Genenta Showcases Strategic Vision at Premier Biotech Forum in Qatar
From GENENTA SCIENCE SPA
Via GlobeNewswire
Genenta Announces €20 million ($21.9M) Financing To Expand Pipeline As Brain Tumor Trial Is Showing Promising Survival Rates
From GENENTA SCIENCE SPA
Via GlobeNewswire
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.